TY - JOUR
T1 - A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit
AU - Rozaliyani, Anna
AU - Sedono, Rudyanto
AU - Jusuf, Anwar
AU - Rumende, Cleopas M
AU - Aniwidyaningsih, Wahju
AU - Burhan, Erlina
AU - Prasenohadi, Prasenohadi
AU - Handayani, Diah
AU - Yunihastuti, Evy
AU - Siagian, Forman E
AU - Jayusman, Achmad M
AU - Rusli, Adria
AU - Sungkar, Saleha
AU - Prihartono, Joedo
AU - Hagen, Ferry
AU - Meis, Jacques F
AU - Wahyuningsih, Retno
PY - 2019/2
Y1 - 2019/2
N2 - OBJECTIVES: To improve the quality of invasive pulmonary aspergillosis (IPA) management for intensive care unit (ICU) patients using a practical diagnostic scoring model.METHODS: This nested case-control study aimed to determine the incidence of IPA in 405 ICU patients, between July 2012 and June 2014, at 6 hospitals in Jakarta, Indonesia. Phenotypic identifications and galactomannan (GM) tests of sera and lung excreta were performed in mycology laboratory, Parasitology Department, Faculty of Medicine, Universitas Indonesia in Jakarta, Indonesia.RESULTS: The incidence of IPA in the ICUs was 7.7% (31 of 405 patients). A scoring model used for IPA diagnosis showed 4 variables as the most potential risk factors: lung excreta GM index (score 2), solid organ malignancy (score 2), pulmonary tuberculosis (score 2), and systemic corticosteroids (score 1). Patients were included in a high-risk group if their score was greater than 2, and in a low-risk group if their score was less than 2.CONCLUSION: This study provides a novel diagnosis scoring model to predict IPA in ICU patients. Using this model, a more rapid diagnosis and treatment of IPA may be possible. The application of the diagnosis scoring should be preceded by specified pre-requisites.
AB - OBJECTIVES: To improve the quality of invasive pulmonary aspergillosis (IPA) management for intensive care unit (ICU) patients using a practical diagnostic scoring model.METHODS: This nested case-control study aimed to determine the incidence of IPA in 405 ICU patients, between July 2012 and June 2014, at 6 hospitals in Jakarta, Indonesia. Phenotypic identifications and galactomannan (GM) tests of sera and lung excreta were performed in mycology laboratory, Parasitology Department, Faculty of Medicine, Universitas Indonesia in Jakarta, Indonesia.RESULTS: The incidence of IPA in the ICUs was 7.7% (31 of 405 patients). A scoring model used for IPA diagnosis showed 4 variables as the most potential risk factors: lung excreta GM index (score 2), solid organ malignancy (score 2), pulmonary tuberculosis (score 2), and systemic corticosteroids (score 1). Patients were included in a high-risk group if their score was greater than 2, and in a low-risk group if their score was less than 2.CONCLUSION: This study provides a novel diagnosis scoring model to predict IPA in ICU patients. Using this model, a more rapid diagnosis and treatment of IPA may be possible. The application of the diagnosis scoring should be preceded by specified pre-requisites.
KW - Adrenal Cortex Hormones/therapeutic use
KW - Case-Control Studies
KW - Humans
KW - Incidence
KW - Indonesia/epidemiology
KW - Intensive Care Units/statistics & numerical data
KW - Mannans/metabolism
KW - Middle Aged
KW - Neoplasms/complications
KW - Predictive Value of Tests
KW - Pulmonary Aspergillosis/complications
KW - Risk Factors
KW - Tuberculosis, Pulmonary/complications
U2 - 10.15537/smj.2019.2.22940
DO - 10.15537/smj.2019.2.22940
M3 - Article
C2 - 30723858
SN - 0379-5284
VL - 40
SP - 140
EP - 146
JO - Saudi medical journal
JF - Saudi medical journal
IS - 2
ER -